NCT05163483 2023-03-06Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric CancerSun Yat-sen UniversityPhase 2 Unknown87 enrolled
NCT02812641 2019-03-11Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCCNational Taiwan University HospitalPhase 2 Unknown50 enrolled